The School of Medicine, The University of Queensland Department of Cardiology, Prince Charles Hospital, Brisbane, Australia.
Heart Lung Circ. 2012 Jun;21(6-7):402-12. doi: 10.1016/j.hlc.2011.10.015. Epub 2012 Jan 9.
The management of ventricular tachycardia (VT) has evolved considerably in recent times. The majority of patients with VT have structural heart disease and often implantable defibrillators. Implantable defibrillators can terminate ventricular arrhythmias and prevent sudden death but do not prevent these arrhythmias from occurring. Ventricular tachycardia may also occur in patients without structural heart disease and although these patients generally have a benign prognosis, the symptoms can be significant. Radiofrequency catheter ablation has a definite role as an alternative to anti-arrhythmic therapy in both groups of patients. This review outlines the indications, techniques and outcomes of catheter ablation in the management of patients with ventricular tachycardia.
室性心动过速（VT）的管理在最近有了很大的发展。大多数 VT 患者都有结构性心脏病，而且经常需要植入除颤器。植入式除颤器可以终止室性心律失常并预防猝死，但并不能预防这些心律失常的发生。室性心动过速也可能发生在没有结构性心脏病的患者中，尽管这些患者的预后通常良好，但症状可能很明显。射频导管消融在这两组患者中作为抗心律失常治疗的替代方法具有明确的作用。这篇综述概述了导管消融在室性心动过速患者管理中的适应证、技术和结果。
